59 results on '"Montine, Thomas J"'
Search Results
2. Cross-species comparative analysis of single presynapses
3. A visual–language foundation model for pathology image analysis using medical Twitter
4. Whole genome deconvolution unveils Alzheimer’s resilient epigenetic signature
5. Characterization of hippocampal sclerosis of aging and its association with other neuropathologic changes and cognitive deficits in the oldest-old
6. Brain proteomic analysis implicates actin filament processes and injury response in resilience to Alzheimer’s disease
7. A peptide-centric quantitative proteomics dataset for the phenotypic assessment of Alzheimer’s disease
8. LATE-NC staging in routine neuropathologic diagnosis: an update
9. Methylation differences in Alzheimer’s disease neuropathologic change in the aged human brain
10. Performance of a fully-automated Lumipulse plasma phospho-tau181 assay for Alzheimer’s disease
11. Single-cell spatial proteomic imaging for human neuropathology
12. Cognition as a mediator for gait and balance impairments in GBA-related Parkinson’s disease
13. Frequency of LATE neuropathologic change across the spectrum of Alzheimer’s disease neuropathology: combined data from 13 community-based or population-based autopsy cohorts
14. Genome-wide association study and functional validation implicates JADE1 in tauopathy
15. Enantiomers of 2-methylglutamate and 2-methylglutamine selectively impact mouse brain metabolism and behavior
16. Single-cell epigenomic analyses implicate candidate causal variants at inherited risk loci for Alzheimer’s and Parkinson’s diseases
17. Multivariate prediction of dementia in Parkinson’s disease
18. Author Correction: Engineering monocyte/macrophage−specific glucocerebrosidase expression in human hematopoietic stem cells using genome editing
19. Engineering monocyte/macrophage−specific glucocerebrosidase expression in human hematopoietic stem cells using genome editing
20. Comparison of regional flortaucipir PET with quantitative tau immunohistochemistry in three subjects with Alzheimer’s disease pathology: a clinicopathological study
21. Large-scale proteomic analysis of Alzheimer’s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation
22. Impact of a deep learning assistant on the histopathologic classification of liver cancer
23. The basis of cellular and regional vulnerability in Alzheimer’s disease
24. Concepts for brain aging: resistance, resilience, reserve, and compensation
25. Omni-ATAC-seq: Improved ATAC-seq protocol
26. An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues
27. Cerebrospinal fluid biomarkers for Alzheimer's and vascular disease vary by age, gender, and APOE genotype in cognitively normal adults
28. The phosphatase calcineurin regulates pathological TDP-43 phosphorylation
29. Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy
30. Obesity and inflammation markers in relation to leukocyte telomere length in a cross-sectional study of persons with Barrett’s esophagus
31. Multiplexed In-cell Immunoassay for Same-sample Protein Expression Profiling
32. PART, a distinct tauopathy, different from classical sporadic Alzheimer disease
33. Primary age-related tauopathy (PART): a common pathology associated with human aging
34. DJ-1 isoforms in whole blood as potential biomarkers of Parkinson disease
35. Apolipoprotein C-I is an APOE genotype-dependent suppressor of glial activation
36. Antagonism of Neuronal Prostaglandin E2 Receptor Subtype 1 Mitigates Amyloid β Neurotoxicity In Vitro
37. The genetics and neuropathology of Alzheimer’s disease
38. Aβ Imaging: feasible, pertinent, and vital to progress in Alzheimer’s disease
39. Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study
40. National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach
41. Role of Cerebrospinal Fluid and Plasma Biomarkers in the Diagnosis of Neurodegenerative Disorders and Mild Cognitive Impairment
42. PD biomarkers—use of α-synuclein reaches new levels
43. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease
44. Mitochondrial therapeutics in Alzheimer's disease and Parkinson's disease
45. Increased Cerebrospinal Fluid F2-Isoprostanes are Associated with Aging and Latent Alzheimer’s Disease as Identified by Biomarkers
46. A patient with Huntington’s disease and long-surviving fetal neural transplants that developed mass lesions
47. Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases
48. F2-Isoprostanes as Biomarkers of Late-onset Alzheimer’s Disease
49. Prostaglandin E2 receptor subtype 2 (EP2) regulates microglial activation and associated neurotoxicity induced by aggregated α-synuclein
50. Apolipoprotein E isoform-dependent dendritic recovery of hippocampal neurons following activation of innate immunity
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.